Better Access Better Healthcare
We improve global healthcare through better access to medicine.
Abacus Medicine is firmly established among the market leaders in the European parallel distribution industry.
Originalis is a parallel distributor of medicine operating in Germany and Ireland.
Abacus Medicine Pharma Services works with Clinical Trial Supply, Commercial Partnerships and Unlicensed Medicines.
Pluripharm is a leading wholesaler in the Netherlands and offers a full line of medicines, medical devices and services to a range of customers.
We are innovative, dedicated
and we care.
The Abacus Medicine Group is built on a strong purpose. When we compete in the market, we help lower the prices on life-critical medicines so that they become more widely available.
The Abacus Medicine Group is a business. We operate commercially, and our activities provide jobs, careers and livelihoods for hundreds of people in dozens of countries.
But we are more than that. When we compete in the market, we help life-critical medicines become more widely available. This gives us a purpose beyond ourselves and is something we can be proud of.
Flemming Wagner
CEO & majority shareholder
Global locations
Employees
Packs sold in 2021
A career in the Abacus Medicine Group
Join a young, ambitious and diverse company.
We are always looking for new and dedicated colleagues.
Latest news
Milestone: 1,000,000,000 euros
Milestone: 1,000,000,000 euros. The combined revenue of the Abacus Medicine Group sets new record. The Abacus Medicine Group has reached another major milestone. Today, the
Abacus Medicine wins 12th Gazelle Award
We have won our Gazelle Award number 12. The Gazelle is awarded by Børsen to the fastest-growing Danish companies of the year. Abacus Medicine has
Allan Dinesen appointed new Chief Operating Officer of the Abacus Medicine Group
Allan Dinesen appointed new Chief Operating Officer of the Abacus Medicine Group. Allan Dinesen becomes the fifth member of an expanded Chief Executive Management Team.